HOME >> MEDICINE >> NEWS
Blood clots can be treated by injections at home

Treatment of blood clots in the deep veins of the legs or the lungs with an older, less expensive form of the anticoagulant medication heparin can be just as safe and effective as similar treatment with a newer and more expensive heparin, according to a study led by Clive Kearon, professor of medicine at McMaster University, published in the August 23 issue of JAMA (The Journal of the American Medical Association).

When injected subcutaneously (beneath the skin), unfractionated (regular) heparin was shown in a randomized trial to work just as well as subcutaneous injection of the more expensive, low-molecular weight heparin in the treatment of venous thromboembolism. Traditionally, when unfractionated heparin is used in treatment, it is administered intravenously and accompanied by coagulation monitoring, which requires hospitalization. This standard approach includes ongoing dose adjustment in response to measurement of the APTT, a test that measures how fast the blood clots in a test tube under certain conditions.

The newer low-molecular weight heparins, which are administered by injection in fixed-weight doses, have gradually been replacing unfractionated heparin.

Kearon and colleagues conducted a randomized trial to study how fixed-dose, subcutaneous injection of unfractionated heparin compared to injection with the newer heparin in the treatment of blood clots in the legs or lungs.

The study was conducted from September 1998 through February 2004 at six university-affiliated clinical centres in Canada and New Zealand. Patients in the trial received either unfractionated or low-molecular-weight heparin administered subcutaneously every 12 hours. About 70 per cent of both groups were treated as outpatients. All patients received three months of warfarin (an anticoagulant drug) therapy.

Recurrent thromboembolism occurred in 3.8 per cent of the 345 patients in the unfractionated heparin group, and in 3.4 perce
'"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
22-Aug-2006


Page: 1 2

Related medicine news :

1. Blood inflammation plays role in Alzheimers disease
2. Blood-thinning drugs need closer monitoring
3. Blood transfusions from precancerous blood donors do not increase risk of cancer
4. Blood marker helps predict prognosis among those with abdominal infection
5. Blood transfusions raise heart patients infection and death risk -- especially women
6. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
7. Blood cells linked to heart attacks, other inflammatory diseases
8. Blood transfusion-transmitted infections: A global perspective
9. Blood pressure variability increases risk for stroke death
10. Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers
11. Canadian Blood Services scientist invents potential alternative for high-demand blood product

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... , ... April 18, 2019 , ... She went from ... pair of eyeglasses, said her mother, Cheryl Reilly. Those “goofy tests,” performed by ... Mikayla Reilly, then 12 years old, had such narrow range of visual awareness, she ...
(Date:4/18/2019)... ... April 18, 2019 , ... As cannabis ... Cannabis Industry Report . The study—which considers consumers’ perceptions of, attitudes about, and ... manufacturing, offering insight into what kinds of products consumers want to see. , ...
(Date:4/17/2019)... ATLANTA (PRWEB) , ... April 17, 2019 , ... Kadan ... nearly 35 years, announced today that it has received both the 2019 Best of ... Pulse. These awards are granted only to the top-ranking home care providers, based on ...
(Date:4/17/2019)... SAN DIEGO (PRWEB) , ... April 17, 2019 ... ... supplement created to help reduce hangover symptoms. This California-made supplement was designed ... productive routines. It is now available for purchase via GotPurpleTree.com and ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... on advances in revolutionary diagnostic technologies. This episode is scheduled to air 3Q ... this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), a ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... April 17, 2019 , ... Stealth ... mitochondrial dysfunction, announced yesterday at the 2019 Muscular Dystrophy Association (MDA) Clinical ... (OLE) clinical trial evaluating efficacy of elamipretide, an investigational product that targets ...
(Date:4/17/2019)... ... April 17, 2019 , ... The Job Research Foundation has ... into the causes of and treatments for Job Syndrome. , The Foundation awarded ... place around the globe in three countries, and on three continents. The recipients are: ...
(Date:4/17/2019)... ... April 17, 2019 , ... Kennywood is making a commitment ... spectrum, have an amazing experience. As part of this commitment, the amusement park ... Board of Credentialing and Continuing Education Standards (IBCCES) to organizations who have completed ...
Breaking Medicine Technology:
Cached News: